Pagsulay sa Dugo alang sa Pagkamabunga sa mga Lalaki: Labaw pa sa Pagsusi sa Semen

Mga Kategorya
Mga Artikulo
Pagkamabungahon sa Lalaki Pagsabot sa resulta sa blood test Update sa 2026 Para sa pasyente

Gisukod sa semen analysis ang gidaghanon; ang gipunting nga mga pagsulay sa dugo ug genetic makatabang sa pagpatin-aw nganong gamay, wala, o nagpakaaron-ingnon nga normal ang gidaghanon. Ang husto nga mga pagsulay nagdepende sa pattern sa semilya, eksaminasyon, ug kasaysayan sa pagpanganak.

📖 ~11 minutos 📅
📝 Nai-publish: 🩺 Medikal nga gisusi: ✅ Batay sa ebidensya
⚡ Paspas nga Summary v1.0 —
  1. Semen analysis una: Ang fertility blood test alang sa mga lalaki makakompleto sa semen analysis; kini wala mosukod sa sperm concentration, motility o morphology.
  2. Hormone trigger: Ang mga lalaki nga adunay azoospermia, sperm concentration ubos sa 10 milyon/mL, ubos nga libido o testicular atrophy kasagaran kinahanglan adunay FSH ug total testosterone nga masukod.
  3. FSH clue: Ang FSH labaw sa laboratory upper limit nga adunay azoospermia kasagaran nagpunting sa nadaot nga sperm production, samtang ang ubos nga FSH ug ubos nga LH nagsugyot og problema sa utok-sa-testis nga pagpahibalo.
  4. Morning testing: Ang total testosterone kinahanglan kuhaon tali sa alas 7 sa buntag ug alas 10 sa buntag ug kumpirmahon sa ikaduhang buntag kon ubos.
  5. Genetic testing: Girekomendar ang Karyotype ug Y-chromosome microdeletion testing alang sa azoospermia o grabe nga oligozoospermia, kasagaran ubos sa 5 milyon nga sperm/mL.
  6. CFTR testing: Ang mga variant sa CFTR gikonsiderar kung ang gidaghanon sa semilya kanunay nga ubos sa 1.4 mL, labi na kung walay vas deferens o obstructive azoospermia.
  7. Prolactin ug thyroid: Ang Prolactin ug TSH kay mga selective test, labing mapuslanon kung aduna'y libido, erectile function, galactorrhoea, mga sintomas sa pituitary, o mga sintomas sa thyroid.
  8. Ayaw pag-inom ug tambal sa imong kaugalingon: Ang mga injection ug gel sa testosterone makapugong sa produksyon sa sperm hangtod sa hapit zero sulod sa mga bulan; ang pagpreserbar sa pagkamabunga nagkinahanglan og espesyalistang pagdumala.

Ngano ang semen analysis nagpabilin nga sinugdanan

Ang pagtuki sa semilya mao gihapon ang unang lakang nga pagsulay alang sa kawala'y pagkamabunga sa lalaki tungod kay ang dugo dili makaihap sa naglihok nga sperm o makatantiya sa ilang porma. Ang pagsulay sa dugo alang sa pagkamabunga alang sa mga lalaki nahimong mapuslanon kung ang resulta sa semilya grabe nga abnormal, wala, dili mohaom sa mga sintomas, o normal bisan pa nga ang magtiayon dili mabdos.

Ang 2021 nga ubos nga reference limit sa World Health Organization mao ang 1.4 mL nga gidaghanon sa semilya, 16 milyon nga sperm/mL nga konsentrasyon, 42% total motility ug 4% normal nga mga porma. Kini ang fifth-centile reference limit gikan sa mga bag-o lang nga fertile nga amahan, dili mga threshold sa pagpanamkon nga pass-or-fail; ang mga pagmabdos mahitabo sa ibabaw ug ubos niini. Ang among detalyado nga giya sa resulta sa pagsulay sa sperm nagpatin-aw ngano nga ang usa ka ubos nga kantidad nagkinahanglan og balik-balik nga pagsulay kaysa usa ka diagnosis.

Ang usa ka sample sa semilya mas nagkalainlain kaysa sa gipaabut sa daghang mga lalaki. Ang hilanat, usa ka 2-ka-adlaw kumpara sa 7-ka-adlaw nga pagpugong sa pagkalalaki, mga lubricant, dili kompleto nga pagkolekta, ug usa ka taas nga biyahe ngadto sa laboratoryo mahimong makaapekto sa resulta. Sa akong klinikal nga praktis, ang usa ka lalaki nga adunay 3 milyon/mL pagkahuman sa trangkaso usahay mibalik 10 hangtod 12 ka semana sa ulahi nga adunay resulta nga daghang pilo nga mas taas, tungod kay ang pag-ugmad sa sperm molungtad mga 74 ka adlaw dugang sa epididymal transit.

Ang normal nga pagtuki sa semilya dili makawagtang sa kontribusyon sa lalaki. Dili kini kasaligang makapakita sa kadaot sa DNA sa sperm, intermittent nga pagbabag, mga sintomas sa endocrine, sexual dysfunction, genetic risk sa mga anak, o kung ang sample nagrepresentar sa kasagaran nga sumbanan. Ang giya sa AUA/ASRM nagtambag sa dungan nga pagsusi sa duha ka kauban tungod kay ang pagkamabunga iya sa magtiayon, dili sa usa ka resulta sa laboratoryo (Schlegel et al., 2021).

Unsa ang mahimo ug dili mahimo sa pagsulay sa dugo

Ang pagsulay sa dugo makaila sa hormonal signalling, systemic illness, ug gipili nga mga hinungdan sa kabilin; dili kini makapuli sa balik-balik nga pagtuki sa semilya nga gihimo sa usa ka eksperyensiyadong andrology laboratory. Hunahunaa ang duha ka pagsulay ingon usa ka pagtantiya sa linya sa produksyon: ang semilya nagpakita sa nahuman nga produkto, samtang ang mga hormone ug mga gene makatabang sa pagpangita og pagkabalda sa taas.

Kanus-a ang male infertility hormone tests labing mapuslanon

Ang mga pagsulay sa hormone sa kawala'y pagkamabunga sa lalaki mao ang labing mapuslanon sa azoospermia, konsentrasyon sa sperm ubos sa 10 milyon/mL, mga sintomas sa sekso, o mga klinikal nga timailhan sa sakit sa endocrine. Dili sila mandatory nga lapad nga screen alang sa matag lalaki nga adunay usa ka gamay nga ubos nga resulta sa motility.

Ang core initial panel kasagaran FSH ug sayo sa buntag nga total testosterone. Idugang ang LH kung ang testosterone ubos, ug idugang ang prolactin kung ang mga sintomas sa sekso, ubos nga gonadotropins, labad sa ulo, o mga sintomas sa panan-aw makapabalaka bahin sa sakit sa pituitary. Ang normal nga konsentrasyon sa testosterone wala magpamatuod sa normal nga produksyon sa sperm, apan ang ubos nga resulta makapausab sa interpretasyon sa FSH ug LH pag-ayo.

Si Kantesti usa ka AI blood test analyzer nga nag-organisar sa mga resulta sa hormone kauban ang kaugalingon nga mga saklaw sa laboratoryo, oras sa pagkolekta, ug mga nangaging kantidad. Kana nga konteksto importante: ang kinatibuk-ang testosterone nga 9.5 nmol/L sa alas 4 sa hapon dili katumbas sa 9.5 nmol/L sa alas 8 sa buntag pagkahuman sa normal nga pagkatulog sa gabii. Alang sa praktikal nga mga isyu sa oras, tan-awa ang among giya sa sampling sa hormone sa buntag.

Kanunay akong makakita og mga referral nga gipahinabo sa usa ka “normal” nga resulta sa testosterone sa usa ka lalaki nga walay sperm. Ang mas mapuslanon nga pangutana mao kung ang iyang FSH nagtubag sa tukma sa ubos nga sperm output. Sa kasukwahi, ang taas nga FSH wala mag-ingon nga ang pagtambal imposible; kini nagsulti sa reproductive urologist nga ang nagpahiping problema mas lagmit ang produksyon sa testicular kaysa usa ka gibabagan nga agianan.

Symptoms that justify a broader endocrine review

Reduced morning erections, markedly reduced libido, loss of body hair, breast tenderness, anosmia, fatigue, headaches or peripheral-vision change are reasons to widen testing. A focused history of anabolic-androgenic steroid use, opioids, antipsychotics, chemotherapy, mumps orchitis and prior groin surgery is often more diagnostic than adding ten unselected biomarkers.

FSH ug LH male fertility patterns nga gigamit sa mga doktor

FSH and LH male fertility results are interpreted as a pair with testosterone and semen findings, not against one universal cutoff. In many adult male laboratories, FSH is about 1.5 to 12.4 IU/L and LH about 1.7 to 8.6 IU/L, but method-specific ranges prevail.

High FSH with azoospermia or severe oligozoospermia supports primary impairment of sperm production. An FSH of 18 IU/L is not a measure of how few sperm remain, and it cannot exclude focal sperm production that may be found by microdissection testicular sperm extraction. The reason is biological: damaged seminiferous tubules produce less inhibin B, so pituitary FSH rises in compensation.

Low or inappropriately normal FSH and LH with low testosterone suggests secondary hypogonadism, meaning inadequate hypothalamic or pituitary drive. This pattern may follow obesity, hyperprolactinaemia, severe illness, opioid exposure, anabolic steroid withdrawal or a pituitary disorder. The low FSH interpretation guide is useful, although no online result can determine the cause alone.

A frankly elevated LH with low testosterone also indicates primary testicular dysfunction, whereas high LH with normal testosterone can represent compensated dysfunction. I tell patients not to overread borderline values: sleep loss, acute illness and assay variation can move a result around the edge of a reference range. Repeating an unexpected result under comparable conditions is usually more sensible than reacting to a decimal point.

Typical adult FSH 1.5-12.4 IU/L Interpret with semen result and local assay range.
Raised FSH >12.4 IU/L With very low sperm count, supports impaired sperm production.
Markedly raised FSH >20 IU/L Often reflects substantial seminiferous-tubule impairment; does not prove no retrievable sperm.
Low gonadotropins with symptoms FSH and LH below range Requires prompt endocrine review when combined with low testosterone, headache or visual symptoms.

Testosterone, SHBG ug estradiol: mapuslanon apan sayon masayop sa pagbasa

A low morning testosterone result should be repeated before diagnosing hypogonadism, and SHBG helps explain discordant total and free testosterone results. Estradiol is selective rather than routine in male fertility work-ups.

Most UK and European laboratories quote adult male total testosterone roughly 8 to 30 nmol/L, while US reports often use about 300 hanggang 1,000 ng/dL. Diagnostic thresholds differ: the Endocrine Society recommends symptoms plus consistently low morning testosterone, rather than a diagnosis from one sample (Bhasin et al., 2018). A result near 8 to 12 nmol/L deserves particular care because assay method and SHBG can change its meaning.

SHBG rises with ageing, hyperthyroidism, liver disease and some anticonvulsants; it can make total testosterone look reassuring while free testosterone is low. SHBG often falls with obesity, insulin resistance, hypothyroidism and androgen exposure, making total testosterone look low even when calculated free testosterone is adequate. Our explanation of SHBG and testosterone covers the calculation limits.

Estradiol is not a surrogate for sperm quality. It can help when obesity, gynecomastia, aromatase-inhibitor use or a testosterone-to-estradiol imbalance is clinically relevant, but standard immunoassays are less reliable at low male estradiol concentrations than sensitive LC-MS/MS methods. Dr. Thomas Klein’s practical rule is simple: treat the patient and pattern, not an isolated estradiol flag.

Why testosterone therapy can harm fertility

External testosterone suppresses pituitary LH and FSH through negative feedback, reducing intratesticular testosterone that sperm production needs. Men hoping to conceive should tell any prescriber before starting injections, gels or pellets; recovery after stopping can take months and is unpredictable, especially after long-term use.

Kanus-a ang prolactin ug thyroid blood tests makadugang bili

Prolactin and thyroid tests identify uncommon but treatable contributors to male infertility when symptoms or gonadotropin patterns point that way. They are not broad fertility screens in otherwise asymptomatic men with isolated mild semen abnormalities.

A prolactin value mildly above range is often transient. Exercise, sexual activity, stress, chest-wall irritation, poor sleep and medicines such as risperidone or metoclopramide may raise it; a calm morning repeat, sometimes with macroprolactin testing, prevents unnecessary imaging. Persistent elevation with low libido, erectile dysfunction, low testosterone, headache or visual symptoms needs clinical evaluation; see why prolactin needs repeating.

TSH uban ang free T4 is reasonable when there are thyroid symptoms, abnormal SHBG, unexplained fatigue, weight change, tremor or abnormal semen volume. Overt hyperthyroidism can disrupt gonadotropin balance and increase SHBG, while severe hypothyroidism can impair libido and erectile function. A normal TSH makes clinically significant primary thyroid failure unlikely, but does not explain every fertility concern.

Si Kantesti usa ka AI blood test interpretation platform that identifies patterns such as low testosterone with low-normal LH and a raised prolactin, then frames them as clinician follow-up prompts rather than diagnoses. A pituitary MRI is considered after medical assessment, particularly for persistent marked prolactin elevation or neurological symptoms; the blood result alone does not choose imaging.

When symptoms are urgent

New severe headache, impaired peripheral vision, confusion, vomiting or rapidly worsening weakness merits urgent medical assessment, whether or not fertility is the original concern. A laboratory panel should never delay evaluation of neurological red flags.

Unsang mga genetic tests ang gipakita sa grabe nga mga abnormalidad sa sperm

Karyotype and Y-chromosome microdeletion testing are usually indicated for azoospermia or severe oligozoospermia, commonly below 5 million sperm/mL. Genetic testing is targeted because its results affect prognosis, sperm-retrieval planning and counselling about offspring.

A karyotype counts and visually assesses chromosomes in cultured white cells. It can detect Klinefelter syndrome, usually 47,XXY, as well as balanced translocations that may matter for embryo chromosome testing. Karyotype does not detect every gene-level variant, so a normal result does not rule out genetic infertility.

The AUA/ASRM guideline recommends karyotype testing for azoospermia or sperm concentration below 5 million/mL when impaired production is suspected, especially with raised FSH or small testes (Schlegel et al., 2021). This threshold is pragmatic, not magical: family history, recurrent pregnancy loss and prior abnormal embryos can justify a genetics discussion at higher concentrations.

A chromosome result can carry emotional weight because it may have implications beyond fertility. I recommend a reproductive urologist or clinical geneticist explain what is inherited, what is not, and whether a partner test changes reproductive choices. For a useful companion discussion, our article on preconception blood testing helps couples coordinate their care.

Why a direct-to-consumer panel is not equivalent

Consumer ancestry genotyping usually examines a restricted set of common variants and cannot replace a clinical karyotype, validated Y-deletion assay or CFTR sequencing strategy. Laboratory method, variant classification and genetic counselling are part of the clinical test, not add-ons.

Y-chromosome microdeletions ug CFTR testing

Y-chromosome microdeletion testing helps predict sperm-production potential, while CFTR testing investigates a possible duct obstruction. These tests answer different questions and should not be ordered interchangeably.

Y-chromosome testing looks for deletions in the AZF regions that contain genes involved in sperm production. Complete AZFa or AZFb deletions make successful sperm retrieval extraordinarily unlikely, whereas many men with AZFc deletions have sperm in ejaculate or can have sperm retrieved. If an AZFc deletion is passed through intracytoplasmic sperm injection, a male child will inherit it.

CFTR testing is considered for congenital bilateral absence of the vas deferens, obstructive azoospermia or persistently low semen volume, especially below the WHO lower limit of 1.4 mL. The partner may need CFTR carrier testing if a pathogenic variant is identified, because two disease-causing variants can cause cystic fibrosis in a child. Semen pH, fructose and examination help direct this decision.

Kantesti, usa ka AI-powered blood test analysis tool, can make a genetic referral easier to understand by keeping hormone, semen and routine laboratory results in one chronological record. It cannot analyse a genetic sequence from a hormone panel, and no AI interpretation should replace pre- and post-test genetic counselling.

A low-volume sample is not always obstruction

Incomplete collection, short abstinence, retrograde ejaculation, androgen deficiency and some medicines can also reduce volume. A repeat sample with documented collection conditions is often the first step before assigning an obstruction label.

Routine blood tests nga nagpadayag sa mga hinungdan sa tibuok lawas

CBC, HbA1c, liver, kidney and selected nutrient tests can uncover illnesses that affect sexual health or endocrine function, but they do not diagnose infertility by themselves. The strongest use is to investigate a symptom, medical history or abnormal hormone pattern.

Diabetes, obesity, chronic kidney disease, liver disease and untreated sleep apnoea can lower testosterone or impair erectile function. An HbA1c nga 6.5% o mas taas meets a diagnostic criterion for diabetes when confirmed appropriately, while 5.7% to 6.4% indicates increased diabetes risk. These thresholds matter because metabolic care improves overall health, although it does not guarantee a semen improvement.

Iron overload is an underappreciated endocrine clue. Ferritin persistently above 300 µg/L in men together with transferrin saturation above 45% can justify evaluation for iron overload, which may affect pituitary and gonadal function; ferritin alone rises with alcohol use, fatty liver and inflammation. Review the full iron-study pattern rather than treating a solitary ferritin number.

Zinc, selenium, vitamin D and folate testing should be driven by diet, malabsorption, bariatric surgery, restrictive eating or a documented deficiency—not by the hope that an expensive supplement stack will repair sperm. High-dose selenium can be harmful; doses above 400 micrograms/day exceed the adult tolerable upper intake level. Our evidence-based review of selenium dose safety explains the margin.

Medication review is a laboratory test of its own

Opioids, anabolic steroids, testosterone, finasteride, some antidepressants, chemotherapy and anti-seizure medicines may affect fertility through different mechanisms. Bring every prescription, injection, supplement and “test booster” to the appointment; stopping a medication without the prescriber can be unsafe.

Unsaon pag-andam alang sa usa ka male fertility blood test

Collect testosterone, LH, FSH and prolactin in the morning, ideally between 7 am and 10 am, after usual sleep and before strenuous exercise. Fasting is not generally required for reproductive hormones, but a fast may be needed when glucose or lipids are ordered simultaneously.

Avoid an intense workout, heavy alcohol intake and overnight shift work immediately before testing when possible. Acute illness can temporarily lower testosterone and change thyroid tests; if the result will guide fertility treatment, defer non-urgent sampling until recovery. Biotin supplements can interfere with some immunoassays, so report doses above 5 mg/day to the laboratory or clinician.

For semen testing, the WHO commonly advises 2 to 7 days of abstinence and reporting the exact interval. The same abstinence window should be used for a repeat whenever possible; comparing a 2-day sample with a 7-day sample can create a false trend. Our giya sa pag-andam alang sa baseline blood test has a practical checklist for mixed panels.

Do not stop prescribed medication merely to produce a “better” result. Instead, record medicines, supplements, fever, recent travel, sleep and collection time alongside the report. Kantesti can preserve this context next to future results, which is often more clinically useful than a colour-coded flag alone.

When to repeat an unexpected result

Repeat a low testosterone result on a separate morning before making a diagnosis unless severe symptoms demand urgent assessment. Semen analysis is commonly repeated after about 2 to 3 months when the first sample is abnormal, but the clinician may repeat sooner if collection quality was clearly compromised.

Unsa kon normal ang semen analysis apan wala mabuntis

Normal semen values do not exclude male-factor infertility, and routine hormone panels are often normal in this situation. The next step is a couple-based review of timing, female factors, sexual function, duration of trying and whether there have been miscarriages or failed assisted-reproduction cycles.

Sperm DNA fragmentation testing may be discussed after recurrent pregnancy loss, repeated assisted-reproduction failure, clinical varicocele, smoking exposure, advanced paternal age or unexplained infertility. It is not yet a universal first-line test because assays and thresholds differ; a high result does not identify one unique treatment. That uncertainty is real, and couples deserve to hear it plainly.

Sexual timing is a surprisingly common missing detail. Intercourse every 1 to 2 days during the 6-day fertile window generally provides good sperm exposure without needing calendar perfection. Erectile dysfunction, pain, ejaculation difficulty and retrograde ejaculation deserve medical attention, not embarrassment; they can be more actionable than another micronutrient panel.

Dr. Thomas Klein has seen couples lose months chasing marginal morphology differences when the more decisive issue was intercourse avoidance after a prior low count. A reproductive urologist can integrate examination findings such as varicocele, epididymal fullness or absent vas deferens with the laboratory picture. Our guide to mga pagsulay sa dugo alang sa ubos nga libido may help prepare for that conversation.

Do not turn a reference limit into a fertility verdict

WHO lower limits describe distributions in fertile men; they are not guaranteed pregnancy thresholds. A concentration of 17 million/mL is not automatically “fertile,” and 14 million/mL is not automatically infertile—the couple’s full clinical picture determines next steps.

Unsaon sa mga resulta sa dugo ug genetic ang pag-usab sa mga kapilian sa pagtambal

Blood and genetic results matter because they can distinguish reversible hormonal suppression, primary sperm-production impairment and obstruction—three pathways with different management. They rarely dictate treatment in isolation.

Secondary hypogonadism may prompt treatment of obesity, hyperprolactinaemia, thyroid disease, medication effects or fertility-preserving hormonal therapy under specialist care. In selected men, clinicians use hCG with or without FSH to stimulate intratesticular testosterone and spermatogenesis; this is different from prescribing external testosterone. Response commonly takes months, not weeks.

High FSH and azoospermia often lead to counselling about micro-TESE, donor sperm or assisted reproduction rather than escalating supplements. The presence of a Y deletion or chromosome difference changes the expected retrieval rate and may change embryo-testing discussions. A genetic result is information, not an instruction to pursue one particular family-building route.

Obstructive patterns—normal-sized testes, normal FSH and low-volume azoospermia, for example—may lead to imaging, reconstruction discussion or surgical sperm retrieval. The male hormone panel guide is a helpful primer before a specialist visit, but treatment should be individualised.

Varicocele is an examination diagnosis as well as a laboratory question

A clinically palpable varicocele with abnormal semen parameters may be treatable in selected couples, but hormone results alone cannot establish it. Scrotal ultrasound can confirm anatomy when the specialist thinks it will alter management, not simply because a semen value is low.

Mga kasagarang sayop sa male fertility blood tests

The commonest mistakes are testing at the wrong time, diagnosing from one result, and using testosterone therapy while trying to conceive. Each error can produce either misleading numbers or avoidable suppression of sperm production.

Do not interpret total testosterone without collection time, SHBG, symptoms and repeat confirmation when it is low. Direct free-testosterone immunoassays are often less reliable than calculated free testosterone using total testosterone, SHBG and albumin, particularly near decision thresholds. A result flagged “low” on an app is a prompt for review, not a diagnosis.

Do not order broad genetic panels after one borderline motility result. Genetic testing has a higher diagnostic yield in azoospermia and severe oligozoospermia, while indiscriminate testing creates variants of uncertain significance that may cause anxiety without changing care. The same principle applies to sperm DNA fragmentation: use it where it may affect a decision.

Si Kantesti usa ka AI lab test interpretation service designed to point out result combinations and questions for a clinician, rather than sell certainty from incomplete data. We encourage users to check source documents carefully; our AI report accuracy checklist is especially useful when a PDF has been scanned or translated.

The supplement trap

Antioxidant combinations have mixed evidence and may not help every man. More is not safer: excessive zinc can cause copper deficiency, while high-dose folic acid can obscure vitamin B12 deficiency; test and treat documented problems with clinician guidance.

Mga resulta ug sintomas nga nagkinahanglan og mas paspas nga pagrepaso sa espesyalista

Azoospermia, very low testosterone with low LH or FSH, persistent marked prolactin elevation, a testicular mass or neurological symptoms warrant prompt medical assessment. These findings are not reasons to panic, but they should not wait for repeated home testing.

A semen result reporting zero sperm should be confirmed with centrifuged pellet examination before permanent conclusions are drawn. The clinician then separates obstruction from production failure using examination, FSH, testosterone, semen volume and sometimes genetics. Cryopreservation may be discussed if rare sperm are found, because a future sample may differ.

Headache with visual-field change, persistent nipple discharge, severe loss of libido and very low morning testosterone can indicate a pituitary problem requiring endocrine assessment. A prolactin result more than several times the upper reference limit raises concern more than a tiny isolated elevation, although laboratories and medicines still need review. Do not drive yourself to emergency care for an isolated borderline result without symptoms; call the clinician who ordered it.

A firm scrotal lump, sudden severe pain, fever with swelling or new breast enlargement requires in-person assessment rather than an online interpretation. Kantesti’s medical advisory board supports our clinician-led safety standards, but urgent physical findings need local medical services.

Where to seek care

A reproductive urologist or andrologist is often the best lead clinician for abnormal male results, working alongside a fertility specialist and endocrinologist when necessary. Ask for the original reports, semen collection details and a clear plan for repeat testing before the visit.

Paggamit sa mga trend sa resulta nga dili puli sa fertility care

Trend review is useful when the same hormone is measured under similar conditions, but it cannot establish fertility or replace a reproductive urology assessment. A meaningful timeline includes units, laboratory method, collection hour, illness and any treatment change.

As of September 3, 2026, Kantesti is used by more than 2 million people across 127+ countries to interpret laboratory documents in multiple languages. Our system can organise FSH, LH, testosterone, prolactin, SHBG and routine markers across reports, but it does not inspect a semen specimen or make a fertility diagnosis.

A change from testosterone 11 to 9 nmol/L may be meaningless if one draw was at 8 am and the other after a night shift. A persistent fall across two or three comparable morning samples is more informative. Use our longitudinal lab trend guide to record conditions that give numbers their clinical meaning.

Privacy matters acutely with fertility and genetic results. Kantesti follows GDPR-aligned, privacy-focused data handling, but users should still remove unnecessary identifiers before sharing reports and decide deliberately who can access a family record. A secure interpretation is useful only if it improves the next clinical conversation.

Questions to bring to the appointment

Ask whether the semen pattern suggests impaired production, obstruction or a temporary factor; whether repeat testing is needed; and whether genetic counselling changes the plan. Also ask explicitly whether any current medication or supplement could suppress sperm production.

Usa ka praktikal nga han-ay human sa dili normal nga resulta sa semilya

After an abnormal semen result, repeat the semen analysis under standard conditions, arrange focused hormone testing when indicated, and see a reproductive urologist for severe abnormalities. This sequence avoids both missed diagnoses and unnecessary panels.

Step one is verification: repeat an abnormal semen analysis after a comparable 2-to-7-day abstinence interval, ideally in a specialist laboratory. Step two is targeted assessment—history, examination, FSH and morning testosterone for azoospermia, severe oligozoospermia or endocrine symptoms. Step three is genetics or imaging only when the pattern supports it.

Bring both partners’ timelines. Duration of trying, maternal age, prior pregnancies, miscarriages, IVF outcomes and intercourse frequency can change urgency and test selection more than a small shift in morphology. For an organised clinician discussion, use our blood test summary checklist rather than relying on memory in a stressful appointment.

Kantesti’s neural network is designed to translate laboratory language into questions you can take to a qualified clinician; our clinical validation approach explains the boundaries of that role. Most patients find that a staged plan is reassuring: not because every answer arrives at once, but because each test has a reason and a next decision attached.

Karon na ang AI-Powered Blood Test Analysis

Apil sa kapin sa 2 milyon nga mga user sa tibuok kalibutan nga nagsalig sa Kantesti para sa dayon ug tukma nga pag-analisa sa lab test. I-upload ang imong resulta sa blood test ug makadawat og komprehensibong pagsabot sa 15,000+ nga mga biomarker sulod sa mga segundo.

⚕️ Pagpasabot sa Medikal

Mga E-E-A-T Trust Signals

Kasinatian

Pagsusi sa klinika nga gipangulohan sa doktor sa mga workflow sa interpretasyon sa lab.

📋

Kahanas

Pokus sa medisina sa laboratoryo kung giunsa paglihok ang mga biomarker sa konteksto sa klinika.

👤

Pagka-awtorisado

Gisulat ni Dr. Thomas Klein ug gisusi ni Dr. Sarah Mitchell ug Prof. Dr. Hans Weber.

🛡️

Kasaligan

Interpretasyon nga base sa ebidensya, nga adunay klaro nga mga agianan sa sunod nga buhat aron makunhuran ang kabalaka.

🏢 Kantesti LTD Narehistro sa England & Wales · Company No. 17090423 London, United Kingdom · kantesti.net
blank
Pinaagi sa Prof. Dr. Thomas Klein

Si Dr. Thomas Klein usa ka board-certified nga klinikal nga hematologist nga nagserbisyo isip Chief Medical Officer sa Kantesti AI. Uban sa kapin sa 15 ka tuig nga kasinatian sa laboratory medicine ug dako nga interes sa AI-suportadong paghubad sa resulta sa blood test, nagtrabaho siya aron ikonektar ang bag-ong teknolohiya sa adlaw-adlaw nga klinikal nga praktis. Ang iyang mga lugar nga interes naglakip sa biomarker analysis, panukiduki sa clinical decision support, ug pag-optimize sa population-specific reference range. Isip CMO, naghatag siya og klinikal nga input sa internal benchmarking sa platform ug naghatag og klinikal nga pagdumala sa kalidad sa medisina sa mga educational report sa Kantesti.

Bilin ug reply

Ang imong email address kay dili mapubliko. Kinahanglan nga mga bakante kay nakamarka *